148:
249:
22:
136:
is a German pharmaceutical company founded in 1988. The company has 300 employees (as of 2023) and revenue of 550 million EUR (2023). Among other products, it makes a biosimilar for
32:
286:
46:
of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be
305:
279:
117:
310:
98:
315:
272:
43:
70:
217:
77:
39:
141:
55:
84:
66:
51:
147:
47:
91:
256:
299:
169:
137:
193:
248:
146:
38:
Please help to demonstrate the notability of the topic by citing
234:
15:
260:
33:
notability guidelines for companies and organizations
255:This German corporation or company article is a
140:under brand name Ranivisio, approved in 2022 by
280:
8:
287:
273:
151:Headquarters of Midas Pharma in Ingelheim
118:Learn how and when to remove this message
161:
194:"Midas Pharma - discover our products"
7:
245:
243:
14:
218:"Ranivisio Authorization details"
247:
20:
1:
130:German pharmaceutical company
259:. You can help Knowledge by
332:
306:Generic drug manufacturers
242:
40:reliable secondary sources
29:The topic of this article
31:may not meet Knowledge's
311:Life sciences industry
152:
150:
316:German company stubs
198:www.midas-pharma.com
174:www.midas-pharma.com
153:
35:
268:
267:
128:
127:
120:
102:
30:
323:
289:
282:
275:
251:
244:
235:Official website
222:
221:
214:
208:
207:
205:
204:
190:
184:
183:
181:
180:
166:
123:
116:
112:
109:
103:
101:
60:
24:
23:
16:
331:
330:
326:
325:
324:
322:
321:
320:
296:
295:
294:
293:
240:
231:
226:
225:
216:
215:
211:
202:
200:
192:
191:
187:
178:
176:
168:
167:
163:
158:
131:
124:
113:
107:
104:
61:
59:
37:
25:
21:
12:
11:
5:
329:
327:
319:
318:
313:
308:
298:
297:
292:
291:
284:
277:
269:
266:
265:
252:
238:
237:
230:
229:External links
227:
224:
223:
209:
185:
160:
159:
157:
154:
129:
126:
125:
108:September 2024
67:"Midas Pharma"
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
328:
317:
314:
312:
309:
307:
304:
303:
301:
290:
285:
283:
278:
276:
271:
270:
264:
262:
258:
253:
250:
246:
241:
236:
233:
232:
228:
219:
213:
210:
199:
195:
189:
186:
175:
171:
165:
162:
155:
149:
145:
143:
139:
135:
122:
119:
111:
100:
97:
93:
90:
86:
83:
79:
76:
72:
69: –
68:
64:
63:Find sources:
57:
53:
49:
45:
41:
34:
27:
18:
17:
261:expanding it
254:
239:
212:
201:. Retrieved
197:
188:
177:. Retrieved
173:
164:
134:Midas Pharma
133:
132:
114:
105:
95:
88:
81:
74:
62:
138:ranibizumab
44:independent
300:Categories
203:2024-09-04
179:2024-09-04
156:References
78:newspapers
52:redirected
170:"History"
42:that are
92:scholar
56:deleted
220:. EMA.
94:
87:
80:
73:
65:
48:merged
99:JSTOR
85:books
54:, or
257:stub
71:news
142:EMA
302::
196:.
172:.
144:.
50:,
288:e
281:t
274:v
263:.
206:.
182:.
121:)
115:(
110:)
106:(
96:·
89:·
82:·
75:·
58:.
36:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
